# Siren Biotechnology receives $8M CIRM grant for AAV gene therapy brain cancer trial

_Friday, June 26, 2026 at 10:23 PM EDT · science · Latest · Tier 2 — Notable_

Siren Biotechnology announced on X on June 26, 2026, that it has been awarded an $8 million non-dilutive CLIN2 grant from the California Institute for Regenerative Medicine. The grant will support the company's Phase 1/2 clinical trial of SRN-101 in adult patients with recurrent high-grade glioma. The post from the account @SirenBio stated the funding comes from CIRM and thanked the organization along with the support of Californians. The announcement included a link to a press release and used the hashtag #cancer. The post was made by Siren Biotechnology, Inc.

## Sources

- [SirenBio](https://x.com/SirenBio/status/2070557911160586454)

---
Canonical: https://techandbusiness.org/newswire/X0O85GNlLhBSz1ObTqO1BE
Retrieved: 2026-06-27T05:54:44.449Z
Publisher: Tech & Business (techandbusiness.org)